King of Prussia, PA, United States of America

James Francis Callahan

USPTO Granted Patents = 64 (Patent Applications = 2)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 9 (Patent Applications = 15)

Average Co-Inventor Count = 3.8

ph-index = 10

Forward Citations = 321(Granted Patents)

Inventors with similar research interests:

Location History:

Collegeville, PA (US) (2002 - 2006)
Philadelphia, PA (US) (1985 - 2007)
King of Prussia, PA (US) (2007 - 2021)
Greenwich, CT (US) (2020 - 2023)

Company Filing History:

27 out of 2,198

Smithkline Beecham Corporation

patents

8 out of 207

Smithkline Beckman Corporation

Glaxosmithkline Intellectual Property Development Limited

patents

5. 5 out of 93

Nps Pharmaceuticals, Inc.

Astex Therapeutics Limited

patents

8. 1 out of 7

Smithkline Beechman Corporation

10. 6 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1985-2023

Loading Chart...

64 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11688017 - Computer system and method for detecting, extracting, weighing, benchmarking, scoring, reporting and capitalizing on complex risks found in buy/sell transactional agreements, financing agreements and research documents (2023-06-27),

2. 11205233 - Computer system and method for detecting, extracting, weighing, benchmarking, scoring, reporting and capitalizing on complex risks found in buy/sell transactional agreements, financing agreements and research documents (2021-12-21),

3. 11117905 - Bisaryl heterocycles as NRF2 activators (2021-09-14),

4. 11078216 - Bisaryl amides as NRF2 activators (2021-08-03),

5. 10783578 - Computerized systems and methods for detecting, risk scoring and automatically assigning follow-on action codes to resolve violations of representation and warranties found in loan servicing contracts, loan purchase and sale contracts, and loan financing contracts (2020-09-22),

6. 10604509 - Nrf2 regulators (2020-03-31),

7. 10485806 - Nrf2 regulators (2019-11-26),

8. 10364256 - Biaryl pyrazoles as NRF2 regulators (2019-07-30),

9. 10351530 - Arylcyclohexyl pyrazoles as NRF2 regulators (2019-07-16),

10. 10272095 - NRF2 regulators (2019-04-30),

11. 9227914 - Calcilytic compounds (2016-01-05),

12. 8980950 - Calcilytic compounds (2015-03-17),

13. 8586631 - Calcilytic compounds (2013-11-19),

14. 8399517 - Calcilytic compounds (2013-03-19),

15. 8354416 - 7,8-dihydropyrido[2,3-d]pyrimidin-4-yl substituted compounds as inhibitors of p38 kinase (2013-01-15),

Title: The Innovative Mind of James Francis Callahan

Introduction: James Francis Callahan, a brilliant inventor hailing from King of Prussia, PA (US), is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: James Francis Callahan holds several patents in various technological domains, including advancements in renewable energy systems, artificial intelligence algorithms, and medical devices.

Career Highlights: With a career spanning over two decades, Callahan has worked with prestigious research institutions and leading tech companies to develop cutting-edge solutions. His work has significantly impacted industries such as healthcare, energy, and information technology.

Collaborations: Throughout his career, James Francis Callahan has collaborated with top engineers, scientists, and researchers from renowned universities and tech firms. His collaborative efforts have led to the creation of innovative products and technologies that have revolutionized the market.

Conclusion: James Francis Callahan's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of inventors. His remarkable contributions continue to inspire future generations of innovators to push the boundaries of what is possible in the realm of technology.

This text is generated by artificial intelligence and may not be accurate.